<DOC>
	<DOCNO>NCT02530294</DOCNO>
	<brief_summary>The study randomize , double-blind , vehicle control , parallel group study , design ass efficacy safety DRM04 Topical Wipes , daily , compare vehicle subject axillary hyperhidrosis .</brief_summary>
	<brief_title>Study DRM04 Subjects With Axillary Hyperhidrosis</brief_title>
	<detailed_description>This randomize , double-blind vehicle control study ass efficacy safety DRM04 topical wipe compare vehicle subject axillary hyperhidrosis . Safety assess lab test , ECG , physical exam vital sign .</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>Male female ≥ 9 year age . Primary , axillary hyperhidrosis least 6 month duration . HDSS 3 4 Baseline . ASDD ≥ 4 Baseline . Sweat production least 50 mg 5 minute axilla assess gravimetrically . Prior surgical procedure hyperhidrosis . Prior axillary treatment antihyperhidrosis medical device ( approved investigational ) . Prior treatment botulinum toxin ( e.g. , Botox® ) axillary hyperhidrosis within 1 year Baseline/Day 1 . Previous active treatment Dermira DRM04HH01 DRM04HH02 clinical trial . Axillary use nonprescription antiperspirant within 1 week prescription antiperspirant within 2 week Baseline . Subjects new regimen psychotherapeutic medication change within 2 month baseline . Treatment systemic anticholinergic within 4 week baseline visit unless dose stable least 4 month . Other treatment glycopyrrolate within 4 week prior Baseline . Secondary axillary hyperhidrosis presence condition may cause secondary hyperhidrosis . History Sjögren 's syndrome Sicca syndrome . History glaucoma , inflammatory bowel disease , toxic megacolon , febrile illness . Men history urinary retention require catheterization due prostatic hypertrophy severe obstructive symptom prostatic hypertrophy . History presence ventricular arrhythmia , atrial fibrillation , atrial flutter . Other systemic disease active uncontrolled infection , condition , judgment Investigator , would put subject unacceptable risk participation study .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>